A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice
2001 ◽
Vol 37
(1)
◽
pp. 106-113
◽
2015 ◽
Vol 47
(4)
◽
pp. 1563-1571
◽
2009 ◽
Vol 25
(2)
◽
2009 ◽
Vol 603
(1-3)
◽
pp. 22-28
◽
2008 ◽
Vol 19
(5)
◽
pp. 287-294
◽